![Marshall H. Woodworth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marshall H. Woodworth
Finanzdirektor/CFO bei NEUROBO PHARMACEUTICALS, INC.
Vermögen: 127 620 $ am 31.05.2024
Profil
Marshall H.
Woodworth's career history includes several positions in the finance field.
He is currently the Chief Financial & Accounting Officer at NeuroBo Pharmaceuticals, Inc. Prior to his current role, he held the position of Chief Financial Officer at Nevakar, Inc. from 2017 to 2023.
Before that, he served as the Chief Financial Officer at Braeburn Pharmaceuticals SPRL from 2015 to 2016.
From 2014 to 2015, he was the Chief Financial Officer at Aerocrine AB.
Marshall also worked at Furiex Pharmaceuticals, Inc. from 2010 to 2013, where he held the roles of CFO, Treasurer & Assistant Secretary.
He started his career as the Vice President-Finance at ANDRITZ Fabrics & Rolls, Inc. from 2006 to 2009.
Mr. Woodworth holds an MBA from Indiana University and an undergraduate degree from the University of Maryland.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.03.2024 | 33 496 ( 0,68% ) | 127 620 $ | 31.05.2024 |
Aktive Positionen von Marshall H. Woodworth
Unternehmen | Position | Beginn |
---|---|---|
NEUROBO PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 27.10.2023 |
Ehemalige bekannte Positionen von Marshall H. Woodworth
Unternehmen | Position | Ende |
---|---|---|
Nevakar, Inc.
![]() Nevakar, Inc. Pharmaceuticals: MajorHealth Technology Nevakar, Inc. is a specialty injectable pharmaceutical company focused on developing innovative products in injectable and ophthalmic space. The company was founded by Navneet Puri in 2015 and is headquartered in Bridgewater, NJ. | Finanzdirektor/CFO | 01.05.2023 |
Braeburn Pharmaceuticals SPRL
![]() Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Finanzdirektor/CFO | 01.10.2016 |
AEROCRINE AB | Finanzdirektor/CFO | 20.04.2015 |
FURIEX PHARMACEUTICALS INC | Finanzdirektor/CFO | 14.11.2013 |
XERIUM TECHNOLOGIES, INC. | Finanzdirektor/CFO | 01.01.2009 |
Ausbildung von Marshall H. Woodworth
Indiana University | Masters Business Admin |
University of Maryland | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NEUROBO PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
ANDRITZ Fabrics & Rolls, Inc.
![]() ANDRITZ Fabrics & Rolls, Inc. TextilesProcess Industries ANDRITZ Fabrics & Rolls, Inc. manufactures and supplies consumable products. It offers pulp, paper, tissue, fiber, stock processing, nonwoven fabrics, industrial rolls, and building and specialty products. The company was founded in 1976 and is headquartered in Youngsville, NC. | Process Industries |
Aerocrine AB
![]() Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Aerocrine AB operates as a specialty pharmaceutical company focused on respiratory disease. The company was founded by Lars E. Gustafsson, Jon Lundberg, Kjell Alving, and Eddie Weitzberg in November 1997 and is headquartered in Uppsala, Sweden. | Electronic Technology |
Furiex Pharmaceuticals, Inc.
![]() Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Furiex Pharmaceuticals, Inc. operates as a drug development collaboration company that uses innovative clinical development design to accelerate and increase value of drug development programs by advancing them through the drug discovery and development process in a cost-efficient manner. Its drug development programs are designed and driven by a core team with extensive drug development experience. Furiex Pharmaceuticals was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Braeburn Pharmaceuticals SPRL
![]() Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Health Technology |
Nevakar, Inc.
![]() Nevakar, Inc. Pharmaceuticals: MajorHealth Technology Nevakar, Inc. is a specialty injectable pharmaceutical company focused on developing innovative products in injectable and ophthalmic space. The company was founded by Navneet Puri in 2015 and is headquartered in Bridgewater, NJ. | Health Technology |